Echo Therapeutics Inc (ECTE) - Financial and Strategic SWOT Analysis Review
Echo Therapeutics Inc (ECTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Echo Therapeutics Inc (Echo Therapeutics) is a medical device and a specialty pharmaceutical company, which develops wireless continuous glucose monitoring (CGM) system. Its product portfolio includes Continuous Glucose Monitoring, which is a CGM System, a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. Echo Therapeutics by utilizing its proprietary AzoneTS transdermal drug reformulation technology also develops Durhalieve, for treatment of corticosteroid-responsive dermatoses. The company works in partnerships with companies such as Ferndale Pharma Group, Inc., Medical Technologies Innovation Asia, Ltd. and Handok Pharmaceuticals to develop market and sell its products. Echo Therapeutics is headquartered in Iselin, New Jersey, the US.
Echo Therapeutics Inc Key Recent Developments
Dec 21,2016: Echo Therapeutics Announces Dismissal of Federal Court Action
Dec 12,2016: Echo Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of Temporary Restraining Order
Aug 12,2016: Echo Therapeutics Announces Second Quarter 2016 Financial Results
May 20,2016: Echo Therapeutics Announces First Quarter 2016 Financial Results
May 17,2016: Echo Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Echo Therapeutics Inc (Echo Therapeutics) is a medical device and a specialty pharmaceutical company, which develops wireless continuous glucose monitoring (CGM) system. Its product portfolio includes Continuous Glucose Monitoring, which is a CGM System, a skin preparation device, transdermal glucose sensor, battery and wireless transmitter. Echo Therapeutics by utilizing its proprietary AzoneTS transdermal drug reformulation technology also develops Durhalieve, for treatment of corticosteroid-responsive dermatoses. The company works in partnerships with companies such as Ferndale Pharma Group, Inc., Medical Technologies Innovation Asia, Ltd. and Handok Pharmaceuticals to develop market and sell its products. Echo Therapeutics is headquartered in Iselin, New Jersey, the US.
Echo Therapeutics Inc Key Recent Developments
Dec 21,2016: Echo Therapeutics Announces Dismissal of Federal Court Action
Dec 12,2016: Echo Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of Temporary Restraining Order
Aug 12,2016: Echo Therapeutics Announces Second Quarter 2016 Financial Results
May 20,2016: Echo Therapeutics Announces First Quarter 2016 Financial Results
May 17,2016: Echo Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
SECTION 1 - ABOUT THE COMPANY
Echo Therapeutics Inc - Key Facts
Echo Therapeutics Inc - Key Employees
Echo Therapeutics Inc - Key Employee Biographies
Echo Therapeutics Inc - Major Products and Services
Echo Therapeutics Inc - History
Echo Therapeutics Inc - Locations And Subsidiaries
Head Office
SECTION 2 – COMPANY ANALYSIS
Echo Therapeutics Inc - Business Description
Echo Therapeutics Inc - Corporate Strategy
Echo Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Echo Therapeutics Inc - Strengths
Echo Therapeutics Inc - Weaknesses
Echo Therapeutics Inc - Opportunities
Echo Therapeutics Inc - Threats
Echo Therapeutics Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Echo Therapeutics Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Dec 21, 2016: Echo Therapeutics Announces Dismissal of Federal Court Action
Dec 12, 2016: Echo Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of Temporary Restraining Order
Aug 12, 2016: Echo Therapeutics Announces Second Quarter 2016 Financial Results
May 20, 2016: Echo Therapeutics Announces First Quarter 2016 Financial Results
May 17, 2016: Echo Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA
May 03, 2016: Echo Therapeutics Announces Significant Progress in Key Development Milestones
Mar 30, 2016: Echo Therapeutics Announces 2015 Financial Results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
Echo Therapeutics Inc - Key Facts
Echo Therapeutics Inc - Key Employees
Echo Therapeutics Inc - Key Employee Biographies
Echo Therapeutics Inc - Major Products and Services
Echo Therapeutics Inc - History
Echo Therapeutics Inc - Locations And Subsidiaries
Head Office
SECTION 2 – COMPANY ANALYSIS
Echo Therapeutics Inc - Business Description
Echo Therapeutics Inc - Corporate Strategy
Echo Therapeutics Inc - SWOT Analysis
SWOT Analysis - Overview
Echo Therapeutics Inc - Strengths
Echo Therapeutics Inc - Weaknesses
Echo Therapeutics Inc - Opportunities
Echo Therapeutics Inc - Threats
Echo Therapeutics Inc - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Echo Therapeutics Inc, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Dec 21, 2016: Echo Therapeutics Announces Dismissal of Federal Court Action
Dec 12, 2016: Echo Therapeutics Announces Federal Court's Denial Of Preliminary Injunction And Lifting Of Temporary Restraining Order
Aug 12, 2016: Echo Therapeutics Announces Second Quarter 2016 Financial Results
May 20, 2016: Echo Therapeutics Announces First Quarter 2016 Financial Results
May 17, 2016: Echo Therapeutics Announces Successful Software Transfer to its Strategic Partner, MTIA
May 03, 2016: Echo Therapeutics Announces Significant Progress in Key Development Milestones
Mar 30, 2016: Echo Therapeutics Announces 2015 Financial Results
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Echo Therapeutics Inc, Key Facts
Echo Therapeutics Inc, Key Employees
Echo Therapeutics Inc, Key Employee Biographies
Echo Therapeutics Inc, Major Products and Services
Echo Therapeutics Inc, History
Echo Therapeutics Inc, Key Competitors
Echo Therapeutics Inc, Ratios based on current share price
Echo Therapeutics Inc, Annual Ratios
Echo Therapeutics Inc, Annual Ratios (Cont.1)
Echo Therapeutics Inc, Interim Ratios
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Echo Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
Echo Therapeutics Inc, Key Facts
Echo Therapeutics Inc, Key Employees
Echo Therapeutics Inc, Key Employee Biographies
Echo Therapeutics Inc, Major Products and Services
Echo Therapeutics Inc, History
Echo Therapeutics Inc, Key Competitors
Echo Therapeutics Inc, Ratios based on current share price
Echo Therapeutics Inc, Annual Ratios
Echo Therapeutics Inc, Annual Ratios (Cont.1)
Echo Therapeutics Inc, Interim Ratios
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Echo Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Echo Therapeutics Inc, Performance Chart (2011 - 2015)
Echo Therapeutics Inc, Ratio Charts
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
COMPANIES MENTIONED
A. Menarini Diagnostics Srl
C8 MediSensors, Inc.
Cygnus Inc
MAQUET Critical Care AB
Optiscan Biomedical Corp
Senseonics, Incorporated
Echo Therapeutics Inc, Performance Chart (2011 - 2015)
Echo Therapeutics Inc, Ratio Charts
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Echo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
COMPANIES MENTIONED
A. Menarini Diagnostics Srl
C8 MediSensors, Inc.
Cygnus Inc
MAQUET Critical Care AB
Optiscan Biomedical Corp
Senseonics, Incorporated